This HTML5 document contains 43 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Subject Item

n2:w

rdf:type

bibo:Article rdac:C10001

dcterms:isPartOf

n10:w

dcterms:subject

n4:lungneoplasms n5:lungcancer n4:screeningpublichealth n4:tobaccouse n8:lungcancer n4:lungcancerrespiratorymedicine n5:afbautofluorescencebronchoscopy n5:preinvasivecarcinoma n5:whitelightbronchoscopy n5:screening n4:smoking n5:autofluorescencebronchoscopy n4:lungcanceroncology n4:healtheducation n4:cardiothoracicsurgery n5:ciscarcinomainsitu n4:healtheffectsoftobaccouse n5:wlbwhitelightbronchoscopy n4:screeningepidemiology n4:screeningoncology

dcterms:title

Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial

rdaw:P10072

n12:print n12:web

vivo:relatedBy

n7:8 n7:13 n7:3 n7:5 n7:2 n7:4 n7:12 n7:10 n7:1 n7:7 n7:9 n7:11 n7:6

dcterms:abstract

Background: The potential of autofluorescence bronchoscopy (AFB) to detect precancerous lesions in the central airways and its role in lung cancer screening is uncertain. A study was undertaken to evaluate the prevalence of moderate/severe dysplasia (dysplasia II-III) and carcinoma in situ (CIS) using a newly developed AFB system in comparison with conventional white light bronchoscopy (WLB) alone. Methods: In a prospective randomised multicentre trial, smokers ⩾40 years of age (⩾20 pack-years) were stratified into four different risk groups and investigated with either WLB+AFB (arm A) or WLB alone (arm B). Results: 1173 patients (916 men) of mean age 58.7 years were included. Overall (arms A and B), preinvasive lesions (dysplasia II-III and CIS) were detected in 3.9% of the patients. The prevalence of patients with preinvasive lesions in the WLB arm was 2.7% compared with 5.1% in the WLB+AFB arm (p = 0.037). For patients with dysplasia II-III, WLB+AFB increased the detection rate by a factor of 2.1 (p = 0.03), while for CIS the factor was only 1.24 (p = 0.75). The biopsy based sensitivity of WLB alone and WLB+AFB for detecting dysplasia II-III and CIS was 57.9% compared with 82.3% (1.42-fold increase). The corresponding specificity was 62.1% compared with 58.4% (0.94-fold decrease). Conclusions: This first randomised study of AFB showed that the combination of WLB+AFB was significantly superior to WLB alone in detecting preneoplastic lesions. Our findings do not support the general use of AFB as a screening tool for lung cancer, but suggest that it may be of use in certain groups. The precise indications await further study.

hub:articleType

n16:other

hub:isPartOfThisJournal

n15:w

bibo:pmid

15923251